Featured Research

from universities, journals, and other organizations

Research identifies risk factors associated with progression of glaucoma

Date:
May 10, 2011
Source:
JAMA and Archives Journals
Summary:
Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a new study.

Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Glaucoma is one of the world's leading causes of permanent vision loss. It is a group of diseases that can lead to damage of the optic nerve and can result in vision loss and blindness. Previous studies of glaucoma risk factors do not always represent the majority of patients or real-world practices in treating them. "The purpose of our study is to verify whether the main risk factors identified in populations enrolled in the major RCTs [randomized clinical trials] can also be applied to populations seen in scenarios that more closely resemble a typical clinical practice," explain the authors.

Carlos Gustavo V. De Moraes, M.D., from the New York Eye and Ear Infirmary, and colleagues collected data from patients who were enrolled in the New York Glaucoma Progression Study and who had at least eight visits for visual field loss. The study included disc photographs; visual field analysis; and measurement of peak intraocular pressure (IOP), the highest level of pressure in the fluid within the eye. A total of 587 eyes of 587 patients were evaluated.

Researchers found that glaucoma was more likely to progress when peak IOP was 18 mm Hg (millimeters of mercury) or higher. Other risk factors included thinning of the cornea, presence of disc hemorrhage in the retina of the eye, and atrophy in part of the eye.

According to the authors, perhaps the most significant findings involved the effect of IOP: "We demonstrated that for each increase in millimeters of mercury in IOP, there is a significant increase in the risk of progression for treated glaucoma patients." Since this is a simple measurement to take in the clinical setting, the findings "may help clinicians decide how aggressively to treat specific patients to slow the rate of glaucoma progression," the authors write. They also pointed to disc hemorrhage as "an indirect sign" of visual field loss that may already have occurred, and erosion of the visual field as well as cornea thinning as predictors of glaucoma progression.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. G. V. De Moraes, V. J. Juthani, J. M. Liebmann, C. C. Teng, C. Tello, R. Susanna, R. Ritch. Risk Factors for Visual Field Progression in Treated Glaucoma. Archives of Ophthalmology, 2011; 129 (5): 562 DOI: 10.1001/archophthalmol.2011.72

Cite This Page:

JAMA and Archives Journals. "Research identifies risk factors associated with progression of glaucoma." ScienceDaily. ScienceDaily, 10 May 2011. <www.sciencedaily.com/releases/2011/05/110509161648.htm>.
JAMA and Archives Journals. (2011, May 10). Research identifies risk factors associated with progression of glaucoma. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/05/110509161648.htm
JAMA and Archives Journals. "Research identifies risk factors associated with progression of glaucoma." ScienceDaily. www.sciencedaily.com/releases/2011/05/110509161648.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins